当前位置:首页 - 行情中心 - 万邦医药(301520) - 财务分析

万邦医药

(301520)

  

流通市值:9.46亿  总市值:28.56亿
流通股本:2207.34万   总股本:6666.67万

万邦医药(301520)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.78亿元,每股收益1.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益150847.39万元,未分配利润37131.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产159984.35万元,负债9136.96万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入293,304,171.94187,214,555.8690,172,342.02341,806,532.85
营业总成本231,528,566.18141,898,897.7265,349,751.67230,811,694.31
营业利润81,466,520.5457,095,567.2132,127,485.39119,006,174.34
利润总额84,055,703.2259,557,656.9532,375,766.77119,644,908.28
净利润77,797,479.7355,032,956.0929,687,084.26108,091,849.31
其他综合收益----
综合收益总额77,797,479.7355,032,956.0929,687,084.26108,091,849.31
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,394,558,447.31,373,171,254.811,376,735,121.421,362,183,442.36
非流动资产合计205,285,097.66197,973,618.82192,064,874.89182,405,946.67
资产总计1,599,843,544.961,571,144,873.631,568,799,996.311,544,589,389.03
流动负债合计71,890,086.6767,511,298.2657,826,672.5266,935,729.77
非流动负债合计19,479,553.4717,924,194.1917,276,480.9413,643,900.67
负债合计91,369,640.1485,435,492.4575,103,153.4680,579,630.44
归属于母公司股东权益合计1,508,473,904.821,485,709,381.181,493,696,842.851,464,009,758.59
股东权益合计1,508,473,904.821,485,709,381.181,493,696,842.851,464,009,758.59
负债和股东权益合计1,599,843,544.961,571,144,873.631,568,799,996.311,544,589,389.03
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计271,468,188.33174,998,652.0577,696,322.08323,773,546.43
经营活动现金流出小计238,554,600.65147,009,513.0677,130,116.07251,848,763.89
经营活动产生的现金流量净额32,913,587.6827,989,138.99566,206.0171,924,782.54
投资活动现金流入小计586,466,383.06383,483,490.78-356,715,349.96
投资活动现金流出小计668,447,895.14458,501,579.3915,317,843.651,389,415,974.8
投资活动产生的现金流量净额-81,981,512.08-75,018,088.61-15,317,843.65-1,032,700,624.84
筹资活动现金流入小计00-1,052,940,021.04
筹资活动现金流出小计31,144,610.8831,144,610.88-24,821,954.73
筹资活动产生的现金流量净额-31,144,610.88-31,144,610.88-1,028,118,066.31
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-80,212,535.28-78,173,560.5-14,751,637.6467,342,224.01
期末现金及现金等价物余额173,284,439.23175,323,414.01238,745,336.87253,496,974.51
TOP↑